<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7103900\results\search\drugs\results.xml">
  <result pre="clinical trials [6]. Chloroquine (CQ) and its less toxic derivative" exact="hydroxychloroquine" post="(HCQ) are well known for their immunomodulating effects in"/>
  <result pre="patients and that its efficacy is enhanced in combination with" exact="azithromycin" post="[11]. HCQ low costs and relative safety profile may"/>
  <result pre="evidence from a small uncontrolled trial in China proves that" exact="tocilizumab" post="in addition to routine therapy is effective for decreasing"/>
  <result pre="inhibiting SARS-CoV-2 infection in vitroCell Discov20206161410.1038/s41421-020-0156-031934347 8.SchrezenmeierEDÃ¶rnerTMechanisms of action of" exact="hydroxychloroquine" post="and chloroquine: implications for rheumatologyNat Rev Rheumatol20201615516610.1038/s41584-020-0372-x32034323 9.RolainJMColsonPRaoultDRecycling of"/>
  <result pre="hydroxychloroquine and chloroquine: implications for rheumatologyNat Rev Rheumatol20201615516610.1038/s41584-020-0372-x32034323 9.RolainJMColsonPRaoultDRecycling of" exact="chloroquine" post="and its hydroxyl analogue to face bacterial, fungal and"/>
  <result pre="COVID-19 associated pneumonia in clinical studiesBiosci Trends2020141727310.5582/bst.2020.0104732074550 11.GautretPLagierJCParolaPHoangVTMeddebLMailheMet al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="of an open-label non-randomized clinical trialInt J Antimicrob Agents202010.1016/j.ijantimicag.2020.105949 12.ChangRSunWZRepositioning" exact="chloroquine" post="as ideal antiviral prophylactic against COVID-19-time is nowPreprints202010.20944/preprints202003.0279.v1 13.RuanQYangKWangWJiangLSongJClinical"/>
 </snippets>
</snippetsTree>
